NYSE ARCA | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 12.29% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 8.36% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.48% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 6.1% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.34% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 4.08% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.41% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.02% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.72% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 2.69% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.41% |
| ELV | Elevance Health Inc | Healthcare | Healthcare Plans | 2.33% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.22% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 1.98% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 1.95% |
| CI | Cigna Corp | Healthcare | Healthcare Plans | 1.91% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.88% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.7% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.66% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.52% |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.